This product is for research use only, not for human use. We do not sell to patients.
Size | Price | Stock |
---|---|---|
500mg | $630 | Check With Us |
1g | $930 | Check With Us |
5g | $2800 | Check With Us |
Cat #: V4862 CAS #: 594839-88-0 Purity ≥ 98%
Description: Tafamidis (also known as Fx-1006 or PF-06291826; Vyndaqel and Vyndamax), a potent and selective transthyretin (TTR) stabilizer, is a medication approved for use in delaying disease progression in adults with certain forms of transthyretin amyloidosis.
Publications Citing InvivoChem Products
Product Promise
- Physicochemical and Storage Information
- Protocol
- Related Biological Data
- Stock Solution Preparation
- Quality Control Documentation
Molecular Weight (MW) | 308.114 |
---|---|
Molecular Formula | C14H7Cl2NO3 |
CAS No. | 594839-88-0 |
Storage | -20℃ for 3 years in powder formr |
-80℃ for 2 years in solvent | |
SMILES Code | O=C(C1=CC=C2N=C(C3=CC(Cl)=CC(Cl)=C3)OC2=C1)O |
Synonyms | Fx-1006, PF06291826; Fx1006, PF-06291826; Fx 1006, Fx-1006A; PF 06291826; Tafamidis; Vyndaqel |
Protocol | In Vitro | Tafamidis binds selectively and with negative cooperativity (Kds ∼2 nM and ∼200 nM) to the two normally unoccupied thyroxine-binding sites of the tetramer, and kinetically stabilizes TTR |
---|
Solvent volume to be added | Mass (the weight of a compound) | |||
---|---|---|---|---|
Mother liquor concentration | 1mg | 5mg | 10mg | 20mg |
1mM | 3.2456 mL | 16.2278 mL | 32.4555 mL | 64.9110 mL |
5mM | 0.6491 mL | 3.2456 mL | 6.4911 mL | 12.9822 mL |
10mM | 0.3246 mL | 1.6228 mL | 3.2456 mL | 6.4911 mL |
20mM | 0.1623 mL | 0.8114 mL | 1.6228 mL | 3.2456 mL |
This equation is commonly abbreviated as: C1 V1 = C2 V2
- (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
- (2) Be sure to add the solvent(s) in order.